Carmela Silvestri

3.0k total citations
82 papers, 2.4k citations indexed

About

Carmela Silvestri is a scholar working on Microbiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Carmela Silvestri has authored 82 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Microbiology, 35 papers in Molecular Biology and 26 papers in Infectious Diseases. Recurrent topics in Carmela Silvestri's work include Antimicrobial Peptides and Activities (58 papers), Antimicrobial Resistance in Staphylococcus (22 papers) and Immune Response and Inflammation (20 papers). Carmela Silvestri is often cited by papers focused on Antimicrobial Peptides and Activities (58 papers), Antimicrobial Resistance in Staphylococcus (22 papers) and Immune Response and Inflammation (20 papers). Carmela Silvestri collaborates with scholars based in Italy, Poland and United States. Carmela Silvestri's co-authors include Oscar Cirioni, Giorgio Scalise, Roberto Ghiselli, Fiorenza Orlando, Vittorio Saba, Andrea Giacometti, Federico Mocchegiani, Wojciech Kamysz, Alberto Licci and Jerzy Łukasiak and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, International Journal of Molecular Sciences and The Journal of Infectious Diseases.

In The Last Decade

Carmela Silvestri

82 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carmela Silvestri Italy	30	1.4k	1.3k	447	408	292	82	2.4k
Mario Campa Italy	27	776 0.6×	767 0.6×	656 1.5×	417 1.0×	179 0.6×	60	2.3k
Sascha A. Kristian United States	18	1.1k 0.8×	601 0.5×	924 2.1×	620 1.5×	167 0.6×	24	2.4k
Marnie L. Peterson United States	30	758 0.6×	500 0.4×	1.1k 2.4×	672 1.6×	231 0.8×	53	2.8k
Richard J. O’Callaghan United States	36	1.4k 1.0×	363 0.3×	716 1.6×	435 1.1×	484 1.7×	128	3.6k
Tomás Maira‐Litrán United States	22	1.4k 1.1×	474 0.4×	649 1.5×	147 0.4×	681 2.3×	27	2.3k
Fionnuala McAleese United States	17	1.5k 1.1×	497 0.4×	1.3k 2.8×	231 0.6×	444 1.5×	22	2.5k
Hidekazu Suginaka Japan	32	1.7k 1.2×	363 0.3×	1.3k 2.8×	229 0.6×	346 1.2×	115	3.3k
John F. Kokai‐Kun United States	27	1.6k 1.2×	516 0.4×	1.8k 4.0×	267 0.7×	196 0.7×	47	3.0k
Natalia Małachowa United States	22	1.5k 1.1×	421 0.3×	1.6k 3.7×	495 1.2×	273 0.9×	35	2.8k
Y. Jerold Gordon United States	27	639 0.5×	700 0.5×	204 0.5×	290 0.7×	107 0.4×	55	2.8k

Countries citing papers authored by Carmela Silvestri

Since Specialization

Citations

This map shows the geographic impact of Carmela Silvestri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmela Silvestri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmela Silvestri more than expected).

Fields of papers citing papers by Carmela Silvestri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmela Silvestri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmela Silvestri. The network helps show where Carmela Silvestri may publish in the future.

Co-authorship network of co-authors of Carmela Silvestri

This figure shows the co-authorship network connecting the top 25 collaborators of Carmela Silvestri. A scholar is included among the top collaborators of Carmela Silvestri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmela Silvestri. Carmela Silvestri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simonetti, Oriana, Oscar Cirioni, Federico Mocchegiani, et al.. (2013). The Efficacy of the Quorum Sensing Inhibitor FS8 and Tigecycline in Preventing Prosthesis Biofilm in an Animal Model of Staphylococcal Infection. International Journal of Molecular Sciences. 14(8). 16321–16332. 30 indexed citations

Simonetti, Oriana, Oscar Cirioni, Roberto Ghiselli, et al.. (2012). Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. European Journal of Clinical Microbiology & Infectious Diseases. 31(11). 3047–3055. 17 indexed citations

Silvestri, Carmela, Oscar Cirioni, Daniela Arzeni, et al.. (2011). In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. European Journal of Clinical Microbiology & Infectious Diseases. 31(8). 1759–1764. 27 indexed citations

Cirioni, Oscar, Guoqiu Wu, Linxian Li, et al.. (2011). S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. Peptides. 32(4). 697–701. 9 indexed citations

Cirioni, Oscar, Małgorzata Dawgul, Roberto Ghiselli, et al.. (2011). In vitro activity and in vivo efficacy of the saponin diosgenyl 2-amino-2-deoxy-β-d-glucopyranoside hydrochloride (HSM1) alone and in combination with daptomycin and vancomycin against Gram-positive cocci. Journal of Medical Microbiology. 60(9). 1337–1343. 12 indexed citations

Cirioni, Oscar, Federico Mocchegiani, Roberto Ghiselli, et al.. (2010). Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. European Journal of Vascular and Endovascular Surgery. 40(6). 817–822. 62 indexed citations

Simonetti, Oriana, Oscar Cirioni, Gaia Goteri, et al.. (2008). Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. Peptides. 29(4). 520–528. 36 indexed citations

Cirioni, Oscar, Carmela Silvestri, Roberto Ghiselli, et al.. (2008). Protective effects of the combination of α-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. Journal of Antimicrobial Chemotherapy. 62(6). 1332–1338. 57 indexed citations

Cirioni, Oscar, et al.. (2007). In vitro activities of tachyplesin III against Pseudomonas aeruginosa. Peptides. 28(4). 747–751. 29 indexed citations

10.

Cirioni, Oscar, Roberto Ghiselli, Wojciech Kamysz, et al.. (2007). Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis. Peptides. 29(1). 31–38. 4 indexed citations

11.

Ghiselli, Roberto, Oscar Cirioni, Andrea Giacometti, et al.. (2007). Comparative Efficacy of Topical Versus Systemic Teicoplanin in Experimental Model of Wound Infections. Journal of Surgical Research. 144(1). 74–81. 9 indexed citations

12.

Cirioni, Oscar, Alessandra Riva, Wojciech Kamysz, et al.. (2007). In Vitro Activity of Aurein 1.2 Alone and in Combination with Antibiotics against Gram-Positive Nosocomial Cocci. Antimicrobial Agents and Chemotherapy. 51(4). 1494–1496. 36 indexed citations

13.

Cirioni, Oscar, Roberto Ghiselli, Fiorenza Orlando, et al.. (2007). Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain*. Critical Care Medicine. 35(7). 1717–1723. 28 indexed citations

14.

Barchiesi, Francesco, Andrea Giacometti, Oscar Cirioni, et al.. (2007). In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH2 alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. Peptides. 28(8). 1509–1513. 16 indexed citations

15.

Ghiselli, Roberto, Oscar Cirioni, Andrea Giacometti, et al.. (2006). THE CATHELICIDIN-DERIVED TRITRPTICIN ENHANCES THE EFFICACY OF ERTAPENEM IN EXPERIMENTAL RAT MODELS OF SEPTIC SHOCK. Shock. 26(2). 195–200. 12 indexed citations

16.

Giacometti, Andrea, Oscar Cirioni, Roberto Ghiselli, et al.. (2005). Comparative Efficacies of Quinupristin-Dalfopristin, Linezolid, Vancomycin, and Ciprofloxacin in Treatment, Using the Antibiotic-Lock Technique, of Experimental Catheter-Related Infection Due to Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 49(10). 4042–4045. 43 indexed citations

17.

Cirioni, Oscar, Andrea Giacometti, Roberto Ghiselli, et al.. (2005). Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Peptides. 27(6). 1210–1216. 42 indexed citations

18.

Giacometti, Andrea, Oscar Cirioni, Roberto Ghiselli, et al.. (2004). The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis*. Critical Care Medicine. 32(12). 2485–2490. 37 indexed citations

19.

Cirioni, Oscar, Wojciech Kamysz, Giuseppina D’Amato, et al.. (2004). In vitro activity and killing effect of the synthetic hybrid cecropin A–melittin peptide CA(1–7)M(2–9)NH2 on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. Diagnostic Microbiology and Infectious Disease. 49(3). 197–200. 30 indexed citations

20.

Cirioni, Oscar, Roberto Ghiselli, Federico Mocchegiani, et al.. (2003). Cathelicidin Peptide Sheep Myeloid Antimicrobial Peptide-29 Prevents Endotoxin-induced Mortality in Rat Models of Septic Shock. American Journal of Respiratory and Critical Care Medicine. 169(2). 187–194. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact